26 results
Thumbnail

D2.182 - Low-dose oral food challenge (OFC) in a pediatric day-care hospital: a pre-immunotherapy approach for managing nut-allergies in children

Thumbnail

D2.183 - Assessment of Incidence and Onset of Eosinophilic Esophagitis during the clinical development of Peanut (Arachis hypogaea) Allergen Powder-dried non-fat protein for oral immunotherapy

Thumbnail

D2.184 - Trends in aeroallergen immunotherapy prescription

Thumbnail

D2.185 - Ultrarush honeybee venom immunotherapy in patients with monoclonal mast cell activation syndrome: two case reports

Thumbnail

D2.186 - Toxicity Assessment of Repeated Doses of Apis mellifera Venom for Immunotherapy

Thumbnail

D2.187 - Can the Conjunctival Allergen Provocation Test Improve Long-Term Adherence to Subcutaneous Allergen-Specific Immunotherapy?

Thumbnail

D2.188 - Low allergenicity of food allergen by Galactomannan Conjugation and immunotherapeutic efficacy of peanut-galactomannan conjugate in a mouse model of peanut allergy

Thumbnail

D2.189 - Eosinophilic Esophagitis Induced by Sublingual Immunotherapy (SLIT): A Rare but Emerging Side Effect

Thumbnail

D2.190 - Unmasking Autoimmunity: A Case of Thyroiditis Emerging After Allergy Immunotherapy

Thumbnail

D2.191 - Autoimmune Disease Unmasked by Allergic Immunotherapy: A Case of Systemic Lupus Erythematosus (SLE) After SCIT

Thumbnail

D2.192 - IgE-Mediated Immunotherapy-Induced Eosinophilic Granulomatosis with Polyangiitis (EGPA)

Thumbnail

D2.193 - Oral Induction of Tolerance to Cow's Milk Protein Allergy in Omani Children: A Retrospective Analysis

Thumbnail

- D3.147 - The inhaled PDE4 inhibitor tanimilast shows a broad anti-inflammatory effect in two mouse models of asthma induced by house dust mite

Thumbnail

- D3.148 - Oscillometry and spirometry derived ratios to assess small airways dysfunction in severe asthma patients taking tezepelumab

Thumbnail

D3.149 - Worse airflow obstruction but not type 2 biomarkers identifies super-responders to tezepelumab in a real life clinic setting

Thumbnail

- D3.150 - Effects of benralizumab on T cell adhesion molecules in severe eosinophilic asthma: modulation by IL-25 and IL-33

Thumbnail

- D3.151 - Prevalence and clinical characteristics of adult asthma patients with different phenotype across GINA step 1 to 5 asthma

Thumbnail

D3.152 - Phenotype and treatment response of allergic patients with severe asthma: a real-world experience from Argentina

Thumbnail

- D3.154 - Safety of allergen immunotherapy in patients with severe asthma. A real-world, multicentre, observational retrospective study

Thumbnail

D3.155 - IL-1 signaling pathway molecules as key markers in childhood severe asthma